|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1393 USD | -1.55% |
|
+0.94% | -76.39% |
| 04-08 | Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors | CI |
| 04-03 | NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding | CI |
On May 1, 2023, Mr. Chad Hellmann resigned as the Chief Financial Officer of NLS Pharmaceutics Ltd. Mr. Hellmann will continue to provide transition services to the company through May 31, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -76.39% | 6.57M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
NLS PHARMACEUTICS LTD. 
